JP2016522202A5 - - Google Patents

Download PDF

Info

Publication number
JP2016522202A5
JP2016522202A5 JP2016514679A JP2016514679A JP2016522202A5 JP 2016522202 A5 JP2016522202 A5 JP 2016522202A5 JP 2016514679 A JP2016514679 A JP 2016514679A JP 2016514679 A JP2016514679 A JP 2016514679A JP 2016522202 A5 JP2016522202 A5 JP 2016522202A5
Authority
JP
Japan
Prior art keywords
cancer
pharmaceutically acceptable
acceptable salt
dihydroquercetin
metformin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016514679A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016522202A (ja
JP6440212B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2014/064354 external-priority patent/WO2014189152A1/en
Publication of JP2016522202A publication Critical patent/JP2016522202A/ja
Publication of JP2016522202A5 publication Critical patent/JP2016522202A5/ja
Application granted granted Critical
Publication of JP6440212B2 publication Critical patent/JP6440212B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016514679A 2013-05-24 2014-05-23 メトホルミン及びジヒドロケルセチンを含む組み合わせ医薬、及びがんの治療のための使用 Expired - Fee Related JP6440212B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013110278 2013-05-24
JP2013110278 2013-05-24
PCT/JP2014/064354 WO2014189152A1 (en) 2013-05-24 2014-05-23 Pharmaceutical combination comprising metformin and dihydroquercetin and its use for the treatment of cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018214368A Division JP6754071B2 (ja) 2013-05-24 2018-11-15 メトホルミン及びジヒドロケルセチンを含む組み合わせ医薬、及びがんの治療のための使用

Publications (3)

Publication Number Publication Date
JP2016522202A JP2016522202A (ja) 2016-07-28
JP2016522202A5 true JP2016522202A5 (enExample) 2017-07-06
JP6440212B2 JP6440212B2 (ja) 2018-12-19

Family

ID=50980347

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016514679A Expired - Fee Related JP6440212B2 (ja) 2013-05-24 2014-05-23 メトホルミン及びジヒドロケルセチンを含む組み合わせ医薬、及びがんの治療のための使用
JP2018214368A Active JP6754071B2 (ja) 2013-05-24 2018-11-15 メトホルミン及びジヒドロケルセチンを含む組み合わせ医薬、及びがんの治療のための使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018214368A Active JP6754071B2 (ja) 2013-05-24 2018-11-15 メトホルミン及びジヒドロケルセチンを含む組み合わせ医薬、及びがんの治療のための使用

Country Status (14)

Country Link
US (4) US9808440B2 (enExample)
EP (1) EP3003296B1 (enExample)
JP (2) JP6440212B2 (enExample)
KR (1) KR102182946B1 (enExample)
CN (1) CN105263484B (enExample)
AR (1) AR096402A1 (enExample)
AU (1) AU2014269401A1 (enExample)
CA (1) CA2912881A1 (enExample)
HK (1) HK1223304A1 (enExample)
PH (1) PH12015502616A1 (enExample)
RU (2) RU2018135973A (enExample)
SG (1) SG11201509555UA (enExample)
TW (2) TWI667021B (enExample)
WO (1) WO2014189152A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10468144B2 (en) 2014-08-19 2019-11-05 Nuscale Power, Llc Spent fuel storage rack
CN105330575A (zh) * 2015-10-14 2016-02-17 吉林海格力斯医药生物科技发展有限公司 一种用于治疗放疗、化疗引起的骨髓损伤的化合物
MX2019003725A (es) 2016-09-30 2019-08-12 Laboratorios Silanes S A De C V Glicinato de metformina, composiciones farmaceuticas que comprenden la misma, y metodos de uso de la misma.
CN108078938A (zh) * 2018-01-15 2018-05-29 栾晓民 一种二氢槲皮素制剂的制备方法及应用
WO2020033019A2 (en) 2018-04-25 2020-02-13 Charles R. Drew University Of Medicine And Science Novel mct4 inhibitors and uses thereof
KR102349477B1 (ko) * 2019-08-30 2022-01-10 (주)프론트바이오 바이구아나이드 계열 화합물 및 플라본, 하이드록시플라본, 플라바논, 플라본 유도체, 하이드록시플라본 유도체, 플라바논 유도체의 복합제를 유효성분으로 함유하는 암 예방 또는 치료용 약학적 조성물
LT4069254T (lt) * 2020-02-25 2024-10-10 Otsuka Pharmaceutical Co., Ltd. Kietos geriamosios vaisto formos, apimančios decitabiną ir cedazuridiną
CN111467332B (zh) * 2020-03-31 2021-08-24 中国科学院苏州生物医学工程技术研究所 低温等离子体与二甲双胍联用的应用
RU2740946C1 (ru) * 2020-06-30 2021-01-21 Федеральное государственное бюджетное научное учреждение "Федеральный исследовательский центр фундаментальной и трансляционной медицины" (ФИЦ ФТМ) Средство для снижения патоморфологических изменений при гиперплазии предстательной железы
US20220409567A1 (en) * 2021-06-23 2022-12-29 Thomas Winston Adjuvant and complementary therapies for the treatment of cancer
CN115154458B (zh) * 2022-07-25 2023-11-10 天水师范学院 一种槲皮素-盐酸二甲双胍复合降糖药物的制备方法
WO2024233616A1 (en) * 2023-05-11 2024-11-14 Wainer Irving W Method for treating cancer
CN118903101B (zh) * 2024-07-29 2026-03-27 哈尔滨医科大学 二氢槲皮素防治三氧化二砷诱导的心脏毒性的用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3523287B2 (ja) * 1993-02-26 2004-04-26 丸善製薬株式会社 発癌プロモーション抑制剤
US8178123B2 (en) 2001-08-29 2012-05-15 Femina Pharma Incorporated Method for augmentation of intraepithelial and systemic exposure of therapeutic agents having substrate activity for cytochrome P450 enzymes and membrane efflux systems following vaginal and oral cavity administration
CN1320925C (zh) * 2005-03-30 2007-06-13 淮北市辉克药业有限公司 长期使用的治疗糖尿病的复方制剂
CA2606658A1 (en) 2006-10-13 2008-04-13 Mike Tyers Compositions and methods for treating neurological disorders or damage
DE102008029460A1 (de) 2008-06-20 2009-12-31 Otkrytoe Aktsionernoe Obschestvo Zavod Ekologicheskoy Tekhniki I Ekopitaniya 'diod' Taxifolinderivate zur Prophylaxe und Behandlung von neurologischen und psychiatrischen Störungen des zentralen Nervensystems
CN102438614A (zh) 2008-10-10 2012-05-02 利默里克生物制药公司 用于治疗的吡喃酮类似物
MX2012002337A (es) * 2009-08-25 2012-06-25 Harvard College Uso de metformina en el tratamiento y prevencion de cancer.
WO2012122295A2 (en) * 2011-03-07 2012-09-13 Ned Biosystems, Inc. Treatment for pancreatic adenocarcinoma and other cancers of epithelial origin
RU2451506C1 (ru) 2011-06-02 2012-05-27 Сергей Юрьевич Лешков Комбинация для лечения сахарного диабета и его осложнений
JP5645796B2 (ja) 2011-11-21 2014-12-24 東京エレクトロン株式会社 液処理装置及び液処理方法

Similar Documents

Publication Publication Date Title
JP2015500225A5 (enExample)
RU2015155283A (ru) Фармацевтическая комбинация, содержащая метроформин и дигидрокверценин, и ее применение для лечения рака
RU2018102078A (ru) Комбинированная терапия противоопухолевым алкалоидом
UA118025C2 (uk) Модулятор андрогенних рецепторів і його застосування
JP2006503919A5 (enExample)
JP2015520753A5 (enExample)
JP2016528246A5 (enExample)
JP2014512356A5 (enExample)
JP2016528162A5 (enExample)
MX2020008258A (es) Formulaciones pediátricas de niraparib y métodos de tratamiento pediátricos.
NZ706836A (en) Methods of treating cancer
PH12016502354A1 (en) Pharmaceutical composition
JP2012082234A5 (enExample)
MX2020011397A (es) Compuestos inhibidores de isocitrato deshidrogenasa 2 (idh2) y el uso de los mismos.
RU2016112608A (ru) Лечение рака комбинацией плинабулина и таксана
JP2014509659A5 (enExample)
ME02470B (me) Nanočesтice nabijene sa hemoterapeutskim anтitumorskim lekom
JP2015096544A5 (enExample)
PH12014502447A1 (en) Use of high dose laquinimod for treating multiple sclerosis
JP2015502926A5 (enExample)
JP2009506054A5 (enExample)
UA117581C2 (uk) Протипухлинний лікарський засіб, який включає низькодозований гідрохлориду іринотекану гідрат
MX2016001541A (es) Uso de anticuerpo inmunoconjugado anti-muc1 maitansinoide para el tratamiento de tumores solidos.
MX2011012491A (es) Administracion continua de cilengitida en tratamientos contra el cancer.
JP2014512355A5 (enExample)